Full-Time

Process Control Specialist

Curia

Curia

1,001-5,000 employees

End-to-end drug development and manufacturing

No salary listed

Albuquerque, NM, USA

In Person

Category
Biology & Biotech (1)
Required Skills
Word/Pages/Docs
Data Analysis
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides

Get referred to Curia

See people who can refer or advise you

Requirements
  • High school diploma or GED
  • Minimum of four (4) years related work experience OR Minimum of three (3) years in pharmaceutical or related industry
  • Must pass a background check
  • Must pass a drug screen
  • May be required to pass Occupational Health Screening
  • Read/interpret SOPs to ensure compliance
  • The ideal candidate should have the ability to read and interpret various documents, such as safety instructions, standard operating procedures, technical procedures, and governmental regulations
  • Proficient in executing arithmetic operations including addition, subtraction, multiplication, and division across various units of measurement, employing whole numbers, fractions, decimals, and percentages. Candidates must possess a strong grasp of algebraic and geometric principles
  • Ability to define problems, collect data, establish facts, and draw valid conclusions. Ability to interpret an extensive variety of technical instructions in mathematical or diagram form and deal with several abstract and concrete variables
  • The ideal candidate will possess a strong technical foundation and proven capability in effectively utilizing diverse software tools to streamline the organization's daily functions. Essential skills encompass adeptness in manufacturing and internet software, alongside proficiency in Microsoft Office tools including PowerPoint, Excel, Word, and Outlook
  • Fosters a collaborative and positive work environment
  • Champions change
  • Promotes a safe and healthy work environment by actively identifying and addressing potential hazards, following established safety protocols, participating in safety training programs, and fostering a culture of awareness and responsibility among team members
  • Demonstrates strong organizational skills and attention to detail
  • Identifies and resolves problems in a timely manner
  • Strives to continuously build knowledge and skills and shares expertise with others
  • Speaks clearly and persuasively; Listens, clarifies, and responds well to questions; Participates effectively in meetings
  • Writes clearly and edits for accuracy; Adapts writing style as needed and presents data effectively
  • Balances team and individual responsibilities; Welcomes feedback; Prioritizes team success and supports others in achieving goals
  • Develops plans, communicates changes, builds commitment, and monitors progress during transitions
  • Seeks continuous improvement and demonstrates accuracy and thoroughness
  • Acts with integrity and respect; Upholds organizational values and inspires trust
  • Develops strategies aligned with organizational strengths and goals
  • Efficiently prioritizes, plans, and organizes tasks to meet objectives
  • Treats others with respect, acts responsibly, and remains tactful under pressure
  • Ensures accuracy, applies feedback, and consistently monitors work quality
  • Meets productivity standards and strives to improve efficiency
  • Follows safety guidelines, reports hazards, and uses materials properly
  • Reliable, on time, and ensures responsibilities are covered when absent
  • Follows instructions, takes responsibility, and completes tasks on time
  • Archival of documents needed to support Production activities
  • Must become fluent in all functional areas in the business unit
  • Read/interpret SOPs to ensure compliance
  • Maintain up to date trainings
  • Other duties as assigned
  • The essential duties and responsibilities items listed in the job description are included in this extraction

Curia is a contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to move medical breakthroughs from concept to market. It provides end-to-end services across the drug development lifecycle, including early research, method development and validation, preformulation, material science, solid-state chemistry, and package device testing. Revenue comes from service contracts for specialized capabilities and expertise, with clients ranging from small startups to large pharma. Curia also collaborates with industry leaders to advance continuous flow development and manufacturing programs. The company differentiates itself through flexible and scalable solutions, deep scientific expertise, and state-of-the-art technology that help clients accelerate development timelines while navigating discovery to commercialization. Its goal is to enable efficient, reliable progression of drug candidates from conception through to market approval.

Company Size

1,001-5,000

Company Stage

Debt Financing

Total Funding

$132M

Headquarters

Albany, New York

Founded

1991

Get referred to Curia

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Flexible, integrated services reduce sponsor handoffs and can accelerate tech transfer.[3][7]
  • Sterile fill-finish and mRNA capabilities position Curia for advanced injectable programs.[1][2]
  • Global capacity and local regulatory know-how support multinational supply redundancy.[4][6]

What critics are saying

  • Lonza, Catalent, Samsung Biologics, and WuXi Bio pressure late-stage pricing and wins.
  • A major FDA warning letter or import alert would disrupt supply and trigger customer exits.
  • Biotech funding downturns delay outsourced development work and weaken Curia's utilization.

What makes Curia unique

  • Curia spans discovery, development, regulatory, and cGMP manufacturing across modalities.[2][7]
  • It offers biologics, small molecules, sterile drug product, and high-potency capabilities.[1][2]
  • Its network covers more than 20 global locations across North America, Europe, India, and Japan.[4][13]

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
The Carlyle Group
Jan 30th, 2026
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR | Carlyle

ALBANY, N.Y. – Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, today announced the completion of its previously announced acquisition by affiliates of The Carlyle Group (“Carlyle”) and affiliates of GTCR LLC (“GTCR”). President and Chief Executive Officer William S. Marth will continue to lead AMRI.

BERNAMA
May 10th, 2024
BIOLOGICS SYMPOSIUM: CURIA, CARTERRA PARTNER TO ADVANCE BIOTECH RESEARCH IN PACIFIC NORTHWEST

KUALA LUMPUR, May 10 (Bernama) - Curia, a contract research, development and manufacturing organisation (CDMO) has announced a partnership with Carterra Inc in hosting a high-throughput biologics symposium slated for May 31, in Seattle, Washington.

PharmiWeb.com
Mar 14th, 2024
Pace® Life Sciences Acquires New Jersey Laboratory From Curia

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network

PPI News Agency
Feb 23rd, 2024
Curia Appoints Steve Lavezoli as Vice President, Biologics

ALBANY, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) - Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26.

Cameroon Online News
Feb 5th, 2024
Curia Receives 2024 CDMO Leadership Award

Curia was awarded based on the feedback of respondents in the Small Pharma category.